GEMS
LIVE

Serial Number

79179809

Owner

Genea IP Holdings Pty Ltd

Attorney

Eric Lamb

Filing Date

Nov 20, 2015

Add to watchlist:

No watchlists yet
View on USPTO

GEMS Trademark

Serial Number: 79179809 • Registration: 5111632

GEMS is a trademark filed by Genea IP Holdings Pty Ltd on November 20, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Genea IP Holdings Pty Ltd (15 trademarks)

L2,

Entity Type: 98

Genea Limited (6 trademarks)

Level 2,

Entity Type: 03

Trademark Details

Filing Date

November 20, 2015

Registration Date

January 3, 2017

Published for Opposition

October 18, 2016

Goods & Services

Culture media for medical use for use to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for medical purposes; cell culture media for medical use for use to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for medical purposes; human cell products, namely, pluripotent and differentiated human cells and stem cells for medical or clinical use; cell culture media for use in medical or medical research applications for cultivating human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes; biological and chemical products and substances for medical use, namely, chemicals for medical or clinical use in relation to assisted reproductive therapies, cell fertilization, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction, chemical preparations for medical or clinical use in relation to assisted reproductive therapies, cell fertilization, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and human reproduction, chemical preparations for the treatment of infertility and other disorders relating to fertility and human reproduction, biological preparations for the treatment of infertility and other disorders relating to fertility and human reproduction, biological preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical reagents for medical use in relation to assisted reproductive therapies, cell fertilization, cell division and cell cultivation and diagnosing and/or treating fertility and other disorders relating to fertility and reproduction; pharmaceutical preparations for the treatment of infertility and other disorders relating to fertility and human reproduction

Cell culture media other than for medical or veterinary use, namely, for laboratory use in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation; cell culture media other than for medical or veterinary use, namely, for scientific and research use in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation; human cell products, namely, pluripotent and differentiated human cells and stem cells for research or scientific purposes; human cell products, namely, pluripotent and differentiated human cells and stem cells for laboratory use excluding medical and veterinary use; biological and chemical products and substances for scientific use other than for medical or veterinary use, namely, chemicals for use in science in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation, chemical preparations for scientific purposes in relation to researching, diagnosing and/or treating infertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation, biological preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical preparations to support growth of human cells, human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, chemical reagents for scientific use in relation to researching, diagnosing and/or treating fertility and other disorders relating to fertility and reproduction and in relation to researching and/or undertaking cell fertilization, division and cultivation

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 7, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Dec 11, 2025 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 9, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 9, 2023 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 8, 2023 APRE
TEAS SECTION 71 RECEIVED
Feb 20, 2023 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Jan 7, 2022 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 3, 2022 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 15, 2019 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 18, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 18, 2019 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 22, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 4, 2017 FICS
FINAL DISPOSITION PROCESSED
Apr 4, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 3, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 3, 2017 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 2, 2016 OPNX
ASSIGNED TO EXAMINER
Nov 15, 2016 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 28, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 28, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 14, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2016 CRFA
ASSIGNED TO LIE
Sep 2, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2016 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 25, 2016 TCCA
CHANGE OF OWNER RECEIVED FROM IB
Jul 1, 2016 CHLD
REFUSAL PROCESSED BY IB
Mar 19, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 1, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 1, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2016 RFCR
NON-FINAL ACTION WRITTEN
Feb 29, 2016 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 9, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 3, 2016 REPR